| Literature DB >> 28684896 |
Yu Wang1, Ji-Xiang Wu2, Shan Guan1.
Abstract
BACKGROUND AND OBJECTIVES: Nipple-sparing mastectomy (NSM) is a widely accepted surgical technique for patients with early breast cancer. The technique improves cosmetic outcomes, but a decrease in nipple sensitivity has been observed with NSM because of the incision into the nipple-areola complex (NAC). Endoscopic nipple-sparing mastectomy with skin lifting system (ENSMSLS) removes all breast tissue through the axillary incision used for the sentinel lymph node biopsy, to avoid incision around the NAC area. With only one incision, NAC sensitivity is less likely to be affected by this technique. We sought to investigate the effect of ENSMSLS on sensation in the NAC, compared with NSM.Entities:
Keywords: Breast reconstruction; Endoscopic nipple-sparing mastectomy with skin lifting system; Nipple-sparing mastectomy; Nipple–areola complex sensitivity
Mesh:
Year: 2017 PMID: 28684896 PMCID: PMC5482913 DOI: 10.4293/JSLS.2017.00028
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Patients' Characteristics
| Characteristic | NSM (n = 30) | ENSMSLS (n = 30) | |
|---|---|---|---|
| Age, years | 43.87 ± 8.27 | 44.57 ± 8.84 | .75 |
| Follow-up, months | 43.22 ± 19.80 | 27.77 ± 20.43 | <.05 |
| Lymph node metastasis, n | 20/30 | 24/30 | .24 |
| Axillary dissection (ALND) | 11 (36.67) | 11 (36.67) | .99 |
| Multiple foci | 11 (36.67) | 13 (43.33) | .60 |
| Chemotherapy | 26 (86.67) | 24 (80.00) | .49 |
| Radiotherapy | 14 (46.67) | 13 (43.33) | .80 |
| Endocrine therapy | 23 (76.67) | 24 (80.00) | .75 |
| Reconstruction method | .96 | ||
| Implant | 18 (60.00) | 19 (63.33) | |
| Skin flap | 10 (33.33) | 9 (30.00) | |
| None | 2 (6.67) | 2 (6.67) | |
| Breast volume | .15 | ||
| A (<150 cc) | 6 (20.00) | 13 (43.33) | |
| B (150–250 cc) | 20 (66.67) | 14 (46.67) | |
| C and above (>250 cc) | 4 (13.33) | 3 (10.00) | |
| Breast-ptosis | 10 (33.33) | 5 (16.67) | .14 |
| SLN | 20 (66.67) | 25 (83.33) | .14 |
| Stage | .87 | ||
| None | 5 (16.67) | 5 (16.67) | |
| I | 4 (13.33) | 4 (13.33) | |
| IIA | 13 (43.33) | 14 (46.67) | |
| IIB | 1 (3.33) | 3 (10.00) | |
| IIIA | 7 (23.33) | 4 (13.33) | |
| Physician satisfied | 22 (73.33) | 23 (76.67) | .77 |
| Patient satisfied | 29 (96.67) | 29 (96.67) | .99 |
Stage: 2 patients of 11 with stage III cancer, who were T2N2M0. both had lymphatic metastasis. Unless otherwise indicated, the data are expressed as the number (% of the total group). ALND, axillary lymph node dissection.
Significantly different.
Comparison of 3 and 6-Month Postsurgery Sensation Status of ENSMSLS Patients With That of NSM Patients
| Parameter | NSM (n = 30) | ENSMSLS (n = 30) | OR | 95% CI of OR | |
|---|---|---|---|---|---|
| Pressure sensation decrease | 28/30 | 12/30 | 21.00 | 4.20, 105.04 | <.0001 |
| (3 months) | |||||
| Pressure sensation decrease | 11/30 | 24.18 | 4.82, 121.61 | <.0001 | |
| (6 months) | |||||
| Temperature sensation decrease | 30/30 | 25/30 | 13.16[ | 0.69, 249.48[ | .02 |
| (3 months)[ | |||||
| Temperature sensation decrease | 23/30 | 19.47[ | 1.06, 358.38[ | .005 | |
| (6 months)[ | |||||
| Vibration sensation loss | 10/30 | 0/30 | 31.24[ | 1.73, 563.16[ | .0006 |
| (3 month)[ | |||||
| Vibration sensation loss | 0/30 | 31.24[ | 1.73, 563.16[ | .0006 | |
| (6 month)[ | |||||
| Nipple transposition | 16/30 | 12/30 | 1.71 | 0.62, 4.77 | .30 |
Sensation status in the matched NSM group was conducted only once, on the day when they were called back for re-examination.
Odds ratio of patients in the NSM surgical group compared with patients in the ENSMSLS group.
Because all the patients in the NSM group had a drop in sensitivity to temperature, the OR cannot be calculated normally. The risk decrease for the ENSMSLS group vs the NSM group was 16.67% in 3 months and 23.33% in 6 months.
All logit estimators with this marker use a correction of 0.5 in every cell of those tables that contain a zero.
For vibration sensation change; because no patients in the ENSMSLS group had lost their vibration sensation, the OR cannot be calculated normally. There was a 33.33% risk decrease for ENSMSLS group compare to NSM group at both the 3 and 6 month follow-ups.
Comparison of Detailed Vibration Sensation Status at 3 and 6 Months After Surgery in the ENSMSLS Group versus the NSM Group
| NSM (Mean ± SD) | ENSMSLS (Mean ± SD) | Difference | Paired | ||
|---|---|---|---|---|---|
| Surgical shake | |||||
| 3 Months postop | 43.96 | 26.66 | 17.30 | 7.74 | <.0001 |
| 6 Months postop | 24.89 | 19.07 | 8.80 | <.0001 | |
| Normal shake | |||||
| 3 Months postop | 5.58 | 6.93 | −1.36 | −0.96 | .3468 |
| 6 Months postop | 6.77 | −1.19 | −0.89 | .3831 |
Shake: force testing in the matched NSM group patients was conducted only once, on the day when the patient was called back for re-examination. Surgical shake, the vibration sensation was tested in the surgical breast at the test points. Normal shake, the vibration sensation was tested in the normal, nonsurgical breast at the test points.